The U.S. Centers for Disease Control and Prevention (CDC) has revised its guidance on COVID-19 vaccines for children, stating that vaccination for healthy individuals aged 6 months to 17 years should follow a “shared clinical decision-making” process. This means that shots are still available, but only if parents and doctors agree it's necessary based on individual circumstances.
The move marks a shift from earlier CDC guidance, which broadly recommended updated COVID-19 vaccines for everyone six months and older. The updated schedule, published Thursday, outlines that if parents want their child vaccinated, they may proceed based on a healthcare provider’s judgment and the family’s preference.
Health Secretary Robert F. Kennedy Jr., a known vaccine skeptic, claimed earlier in the week that COVID vaccines for healthy children and pregnant women had been removed from the CDC’s immunization schedule. However, a Department of Health and Human Services spokesperson said there is no contradiction, as the CDC’s updated guidance no longer promotes universal vaccination for healthy children but still allows it case-by-case.
Medical experts criticized Kennedy’s unilateral announcement, saying it bypassed the CDC’s usual advisory process. The Infectious Diseases Society of America warned the change may limit access and insurance coverage, especially for vulnerable children. They emphasized that COVID-19 can cause serious illness in children, including long COVID symptoms that may impact development.
According to CDC data, nearly 1,900 children under 18 have died from COVID-19 in the U.S. as of 2023. Vaccine makers Pfizer, Moderna, and Novavax have not commented on the development.
The FDA also recently announced it would require new clinical trials for annual COVID boosters in healthy individuals under 65, reinforcing a more limited use strategy moving forward.


U.S. Fast-Tracks $8.6 Billion Arms Sales to Middle East Allies Amid Rising Tensions
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
FDA Biologics Chief Vinay Prasad to Leave Agency in April Amid Policy Disputes
U.S. Sanctions Former DR Congo President Joseph Kabila Over Rebel Support
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1
Dominican Republic Halts GoldQuest Mining Project Amid Environmental Protests
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
CDC Acting Director Urges Measles Vaccination as U.S. Cases Surge in 2026
U.S. Flags Vietnam as “Priority Foreign Country” Over Intellectual Property Concerns
Trump Administration Dismisses Entire National Science Board, Sparking Debate Over Scientific Independence
The four types of dementia most people don’t know exist
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
US to Withdraw 5,000 Troops from Germany Amid Growing Rift with European Allies
US Adds European Union to Section 301 Watchlist Amid Trade Concerns
Judge Delays SEC Settlement With Elon Musk Over Twitter Stock Disclosure Case
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint 



